435 related articles for article (PubMed ID: 28605056)
21. Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease.
Loftus AM; Bucks RS; Thomas M; Kane R; Timms C; Barker RA; Gasson N
J Int Neuropsychol Soc; 2015 Feb; 21(2):137-45. PubMed ID: 25666735
[TBL] [Abstract][Full Text] [Related]
22. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and treatment pattern of Parkinson's disease dementia in Korea.
Oh YS; Kim JS; Park IS; Shim YS; Song IU; Park JW; Lee PH; Lyoo CH; Ahn TB; Ma HI; Kim YD; Koh SB; Lee SJ; Lee KS
Geriatr Gerontol Int; 2016 Feb; 16(2):230-6. PubMed ID: 25656841
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal study of normal cognition in Parkinson disease.
Pigott K; Rick J; Xie SX; Hurtig H; Chen-Plotkin A; Duda JE; Morley JF; Chahine LM; Dahodwala N; Akhtar RS; Siderowf A; Trojanowski JQ; Weintraub D
Neurology; 2015 Oct; 85(15):1276-82. PubMed ID: 26362285
[TBL] [Abstract][Full Text] [Related]
25. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
[TBL] [Abstract][Full Text] [Related]
26. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
[TBL] [Abstract][Full Text] [Related]
27. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
Goldman JG; Holden S; Ouyang B; Bernard B; Goetz CG; Stebbins GT
Mov Disord; 2015 Mar; 30(3):402-6. PubMed ID: 25449653
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis.
Baiano C; Barone P; Trojano L; Santangelo G
Mov Disord; 2020 Jan; 35(1):45-54. PubMed ID: 31743500
[TBL] [Abstract][Full Text] [Related]
29. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
Vasconcellos LF; Pereira JS
J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
[TBL] [Abstract][Full Text] [Related]
30. Mild cognitive impairment in Parkinson's disease: Characterization and impact on quality of life according to subtype.
Vasconcellos LFR; Pereira JS; Charchat-Fichman H; Greca D; Cruz M; Blum AL; Spitz M
Geriatr Gerontol Int; 2019 Jun; 19(6):497-502. PubMed ID: 30912284
[TBL] [Abstract][Full Text] [Related]
31. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease.
Cholerton B; Johnson CO; Fish B; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Hu SC; Mata IF; Leverenz JB; Poston KL; Montine TJ; Zabetian CP; Edwards KL
Parkinsonism Relat Disord; 2018 May; 50():29-36. PubMed ID: 29478836
[TBL] [Abstract][Full Text] [Related]
32. [Mild cognitive impairment in Parkinson's disease].
Wada K; Nakashima K
Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
[TBL] [Abstract][Full Text] [Related]
33. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
34. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
[TBL] [Abstract][Full Text] [Related]
35. Addenbrooke's cognitive examination III: diagnostic utility for detecting mild cognitive impairment and dementia in Parkinson's disease.
Sousa NMF; Brucki SMD
Arq Neuropsiquiatr; 2023 Feb; 81(2):155-163. PubMed ID: 36863401
[TBL] [Abstract][Full Text] [Related]
36. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.
Chung SJ; Shin JH; Cho KH; Lee Y; Sohn YH; Seong JK; Lee PH
Mov Disord; 2017 Oct; 32(10):1447-1456. PubMed ID: 28737237
[TBL] [Abstract][Full Text] [Related]
37. Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors.
Wang Q; Zhang Z; Li L; Wen H; Xu Q
Clin Interv Aging; 2014; 9():275-81. PubMed ID: 24550669
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
[TBL] [Abstract][Full Text] [Related]
39. Mild Cognitive Impairment in Parkinson's Disease-What Is It?
Weil RS; Costantini AA; Schrag AE
Curr Neurol Neurosci Rep; 2018 Mar; 18(4):17. PubMed ID: 29525906
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of Patient and Care Partner Identification of Cognitive Impairments in Parkinson's Disease-Mild Cognitive Impairment.
Copeland JN; Lieberman A; Oravivattanakul S; Tröster AI
Mov Disord; 2016 May; 31(5):693-8. PubMed ID: 27028432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
